MarketWatch
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.
View original source — MarketWatch ↗
Related stories
CNBC
WorldJun 19, 2026 · 1 min
Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker
CNBC
MarketWatch
WorldJun 8, 2026 · 1 min
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
MarketWatch
Rio Times
PoliticsJun 16, 2026 · 1 min
Brazil’s Weight-Loss Drug Market Enters a Price War
Rio Times
CNBC
WorldJun 8, 2026 · 1 min
Weight loss drug maker sinks 25% after new safety data spooks investors
CNBC